- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08:18 | UBS assumes coverage on Apollo Global Management stock with Buy rating | ||
| 08:18 | UBS assumes coverage on Blackstone stock with Neutral rating | ||
| 08:18 | Carlyle Group stock rating initiated at Buy by UBS on growth outlook | ||
| 08:18 | BlackRock stock rating initiated at Neutral by UBS with $1,180 target | ||
| 08:18 | Brookfield Asset Management stock coverage resumed by UBS with Neutral rating | ||
| 08:18 | Bernstein initiates BridgeBio Pharma stock coverage with Outperform rating | ||
| 08:18 | B.Riley initiates Chime Financial stock with Buy rating on growth potential | ||
| 07:42 | Sampo repurchases over 260,000 shares in ongoing buyback program | ||
| 07:42 | Hamilton Lane stock coverage resumed at UBS with Buy rating on wealth strategy potential | ||
| 07:42 | UBS initiates KKR stock with Buy rating, sees firm beating 2026 targets | ||
| 07:42 | Freedom Capital Markets upgrades Glencore stock to Buy on copper strategy | ||
| 07:42 | UBS assumes coverage on Houlihan Lokey stock with Neutral rating | ||
| 07:42 | JPMorgan reinstates Experian stock with Overweight rating on AI potential | ||
| 07:42 | UBS upgrades Jefferies stock to Buy with $76 price target | ||
| 07:42 | UBS assumes coverage of Blue Owl Capital stock with Neutral rating | ||
| 07:42 | Moelis stock rating initiated at Neutral by UBS on sponsor-backed M&A concerns | ||
| 07:42 | PJT Partners stock coverage initiated at Neutral by UBS with $180 target | ||
| 07:42 | UBS assumes coverage of LPL Financial stock with Neutral rating | ||
| 07:30 | Zealand Pharma partners with OTR Therapeutics on metabolic disease drugs | ||
| 07:30 | BioVersys initiates phase 3 trial for BV100 antibiotic candidate | ||
| 07:30 | Zealand Pharma and OTR Therapeutics form metabolic disease partnership | ||
| 07:30 | Antin to acquire data center operator NorthC from DWS | ||
| 07:30 | UBS assumes coverage on Charles Schwab stock with Buy rating | ||
| 07:30 | Raymond James stock rating initiated at Neutral by UBS with $176 price target | ||
| 07:30 | TPG stock rating initiated with Buy at UBS, price target set at $82 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .